Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Ustekinumab-Single Dose	STARTED	Cohort 1: Single-dose Phase 1, Multi-dose Phase 2	3
Ustekinumab-Single Dose	STARTED	Cohort 2: Multi-Dose Ustekinumab Phase 2	0
Ustekinumab-Single Dose	COMPLETED	Cohort 1: Single-dose Phase 1, Multi-dose Phase 2	3
Ustekinumab-Single Dose	COMPLETED	Cohort 2: Multi-Dose Ustekinumab Phase 2	0
Ustekinumab-Single Dose	NOT COMPLETED	Cohort 1: Single-dose Phase 1, Multi-dose Phase 2	0
Ustekinumab-Single Dose	NOT COMPLETED	Cohort 2: Multi-Dose Ustekinumab Phase 2	0
Ustekinumab-Multi-dose	STARTED	Cohort 1: Single-dose Phase 1, Multi-dose Phase 2	3
Ustekinumab-Multi-dose	STARTED	Cohort 2: Multi-Dose Ustekinumab Phase 2	2
Ustekinumab-Multi-dose	COMPLETED	Cohort 1: Single-dose Phase 1, Multi-dose Phase 2	3
Ustekinumab-Multi-dose	COMPLETED	Cohort 2: Multi-Dose Ustekinumab Phase 2	2
Ustekinumab-Multi-dose	NOT COMPLETED	Cohort 1: Single-dose Phase 1, Multi-dose Phase 2	0
Ustekinumab-Multi-dose	NOT COMPLETED	Cohort 2: Multi-Dose Ustekinumab Phase 2	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02199496/flow